Type 1 diabetes (T1D) occurs through a breakdown of self-tolerance resulting in the autoimmune destruction of the insulin producing β-islets of the pancreas. A numerical and functional waning of CD4 +
presses CXCR3 in the pancreatic lymph nodes (pLN) in response to T eff cell-mediated pancreatic inflammation, an expression correlating with the onset and magnitude of IFN-γ production by T eff cells in pancreatic sites. We also reveal that intra-pancreatic APC populations and insulin-producing β, but not α nor δ, islet cells secrete the CXCR3 chemokines, CXCL9, 10 and 11, and selectively promote ICOS + CXCR3
+ T reg cell chemotaxis in vitro.
Strikingly, islet-derived T reg cells also produce these chemokines suggesting an auto-regulation of homing by this subset. Unlike ICOS -cells, ICOS + T reg cells adopt a Th1-like T reg phenotype while maintaining their suppressive capacity, characterized by expression of Tbet and CXCR3 and production of IFN-γ in the draining pLNs. Finally, in vivo neutralization of IFN-γ blocked T reg cell CXCR3 upregulation evincing its role in regulating expression of this chemokine receptor by T reg cells. Thus, CXCR3-mediated trafficking of T reg cells could represent a mechanism of homeostatic immunoregulation during diabetogeneesis.
Introduction
Mechanisms of peripheral immune self-tolerance prevent the onset and progression of pathological autoimmune responses. Immunosuppressive CD4 + Foxp3 + T regulatory (T reg ) cells, constitutively expressing CD25 (IL-2Rα), develop in the thymus (tT reg ) or differentiate from non-regulatory CD4 + Foxp3 -T effector (T eff ) cells in vitro (iT reg ) or in the periphery (pT reg ) [1] , [2] . In order to establish and maintain dominant self-tolerance, T reg cells employ a plethora of immunosuppressive mechanisms including production of anti-inflammatory cytokines like TGF-β and IL-10, thereby inhibiting T eff cell expansion and effector functions. Developmental blockade of this lineage in mice via day 3 thymectomy provokes lympho-proliferative and multi-organ autoimmune disease [1] . Similarly, loss-of-function mutations in the T reg cell lineage-specifying transcription factor Foxp3 abrogate T reg cell development, resulting in severe autoimmunity in scurfy mice and immunodysregulation polyendocrinopathy enteropathy Xlinked syndrome (IPEX) in humans [3] . NOD mice succumb to autoimmune diabetes resulting from a T-cell dependent destruction of the insulin producing β-islets of Langerhans [4] . Diabetogenesis in the NOD model shares many features with human T1D including insulin-responsive hyperglycemia, common risk loci, and the development of pancreas-specific auto-antibodies [4] . Inflammatory infiltrates are observed in the islets at 3-4 weeks of age however outright insulitis does not occur until 4-8 weeks later, suggesting immunoregulatory mechanisms are at least partially intact during this period. BDC2.5-NOD mice carry a transgenic TCR specific to a β-islet antigen, facilitating reliable, synchronous diabetes onset and transfer of diabetes via infusion of cells into lymphopenic hosts. Progression to insulitis in NOD and BDC2.5 mice results from the failure of multiple central and peripheral immune checkpoints. This includes a progressive waning in function and number of intra-islet T reg cell populations [5, 6, 7] . Recently, we and others have implicated an islet-specific deficiency in IL-2, a cytokine critical for T reg cell homeostasis, in the functional waning of T reg cells at the onset of insulitis [8, 9, 10] . Conversely, low dose IL-2 therapy both maintains pancreatic T reg cell populations and protects NOD mice from T1D [9, 7] . In addition, we recently demonstrated a critical dependence on the ICOS co-stimulatory pathway for the survival and function of intra-pancreatic T reg cells [7] . Specifically, the ICOS + T reg cell subset, predominates in the islets of pre-diabetic NOD mice, and preferentially survives, proliferates and suppresses effector responses in situ. A decline in ICOS expression by T reg cells accompanies the progression to insulitis whereas IL-2 therapy selectively maintains the intra-islet ICOS + T reg cell pool and protects from T1D. Furthermore, co-transfer of ICOS + T reg cells, but not their ICOS -or icos deficient (ICOS -/-) counterparts, protects lymphopenic NOD recipients from T eff cell-induced insulitis and disease. Thus, a local network of cytokine and co-stimulatory mechanisms can co-ordinate T reg cell homeostasis in the pre-diabetic islets of autoimmuneprone mice.
While ICOS + T reg cells preferentially accumulate in the pre-diabetic islets, the distinct mechanisms that mediate homing are unclear. Thus, we hypothesized that ICOS could also play a role in their preferential homing and accumulation of T reg cells in pancreatic sites of BDC2.5 TCR transgenic NOD mice. Recent studies have identified T reg sub-populations that express T eff cell-associated genes critical for their trafficking to sites of inflammation [11] . Notably, IFN-γ was shown to induce T-bet and CXCR3 expression in T reg cells, thus promoting their homing to sites of type-1 inflammation [12] . Similarly, IRF4 and STAT3 expression by T reg cells is necessary for suppression of pathogenic Th2 and Th17 responses, respectively [13, 14] . Given that ICOS + T reg cells represent a dominant, suppressive subset that accumulates in a 
Materials and Methods Mice
NOD.TCRα -/-mice were a generous gift from C. Benoist (Harvard University). BDC2.5.
Foxp3
GFP ICOS -/-, BDC2.5.Foxp3 GFP and BDC2.5. Foxp3 GFP Thy1.1 mice were generated in house. All mouse strains were maintained in SPF conditions at RI-MUHC.
Antibodies and flow cytometry
Single cell suspension prepared from different organs were stained and acquired on FACSCanto (BD) or BD Fortessa and analyzed with FlowJo software (Tree Star). Surface phenotype staining was done with the following fluorochrome-conjugated or biotinylated mAbs: anti-CD3 (145-2c11), anti-CD4 (RM5), anti-ICOS (7E.17G9), anti-Thy1.1 (HIS51), anti-CD11c (HL3), anti-F4/80 (BM8), anti-CXCR3 (cxcr3-173), and anti-IFN-γR (2E2). The expression of Foxp3 (FJK-16s), T-bet (ebio4B10), CXCL9 (MIG-2F5.5) (eBioscience, San Diego, CA), CXCL10 (CL9177B) (Cedarlane, Burlington, ON), CXCL11 (rmCXCL11) (R&D systems, Burlington, ON), Ki-67 (B56) (BD Bioscience, Mississauga, Ontario) was determined by intracellular staining performed according to manufacturers' protocols. The STAT1 phosphorylation assay was done following BD recommendations. To evaluate cytokine production, T cells were re-stimulated for 4hrs at 37°C with PMA (20ng/ml), ionomycin (1nM) (Sigma-Aldrich, Oakville, Canada) and BD GolgiStop TM (1:1000 dilution), and then stained intracellularly with anti-IFN-γ (XMG1.2) (eBioscience, San Diego, CA). T-bet fluorescence minus one (FMO) control and antibody titration is displayed in S1E Fig.
Cell purification
For some in vivo adoptive transfer studies, T reg and T eff cells from respective mouse strains were purified from splenocytes and LN cells either based on CD4 and CD25 expression using the autoMACS cell sorter, using BDC2. [7] . In vivo ICOS blockade induces changes in the gene expression profile of intra-pancreatic T reg cells, including genes encoding various chemokine receptors, such as CCR2, CCR5 and CXCR3 [15] . This prompted us to examine whether specific chemokine receptors, regulated in part by inflammation, could promote ICOS + T reg trafficking to the β-islets.
We initially screened ICOS + or ICOS -T reg cells for expression of chemokine receptors including CXCR3, CCR2, CCR7, CCR4, CCR9, CXCR5 and CCR6 (data not shown). We found that in contrast to other T cell subsets, ICOS + T reg cells displayed marked CXCR3 expression in the draining pLNs of pre-diabetic BDC2.5 NOD mice. Specifically, CXCR3 was highly expressed by ICOS + T reg cells, relative to ICOS -T reg cells in terms of both frequency (52.9% vs. lymphoid tissues ( Fig 1A) . Though ICOS + T reg cells did not express CXCR3 in the pancreas, CXCR3 is known to undergo rapid internalization and degradation upon encounter with its ligands at the site of inflammation [16] . Moreover, T reg cells from BDC2.5 ICOS -/-mice expressed low CXCR3 at all sites examined, indicating that CXCR3 expression in T reg cells is regulated by ICOS (Fig 1B) . Unexpectedly, only a low fraction T eff cells expressed CXCR3 in BDC2.5 mice in all sites examined (S1A Fig) . Overall, ICOS-dependent CXCR3 expression coincided with specific accumulation of ICOS + T reg cells within the target organ, suggesting this subset may use CXCR3 to home to pancreatic sites.
Autoreactive T cell-mediated inflammation induces CXCR3 expression by ICOS + T reg cells prior to T1D onset
Pro-inflammatory cytokines modulate expression of chemokine receptors to induce immune infiltration of the inflammatory lesion. Thus, we hypothesized that expression of CXCR3 is induced on T reg cells in response to intra-pancreatic inflammatory events. Most notably, intraislet IFN-γ production, primarily by T eff cells, was of particular interest considering its various inflammatory actions on immune and islet cells in NOD mice. To determine if inflammation influenced ICOS + T reg cell homing to pancreatic sites, we reconstituted NOD.TCRα -/-mice with CD4 + CD25 -T eff (almost exclusively GFP -) or CD4 + CD25 + T reg cells from BDC2.5. 
Foxp3
GFP reporter mice either alone or at different T eff /T reg cell ratios to mimic different inflammation levels. The transfer of BDC2.5 T cells in NOD.TCRα -/-mice reliably and predictably induces different levels of pancreatic inflammation, and allows for the tracking of T cell functional dynamics at T1D onset and progression. As expected, mice receiving only T eff cells succumbed to rapid T1D onset by day 12 (data not shown), and this correlated with increased production of IFN-γ by auto-reactive T eff cells in the pLN (S1B Fig) and pancreas (Fig 1C) . Interestingly, CXCR3 was readily expressed on ICOS + T reg cells in all mice co-transferred with T reg cells. The frequency of CXCR3 + T reg cells declined with decreased T eff cell-induced inflammation suggesting that pancreatic inflammation promotes the induction of CXCR3 on T reg cells (40% at 1:12 ratio, 30% at 1:5 ratios, and 21% with T reg cells alone) (Fig 1D) . Intriguingly, our results show that mice reconstituted with T eff cells alone contained the highest frequency of CXCR3 + T reg cells in the pLN on day 12 (49%) suggesting that CXCR3 can be readily upregulated amongst pT reg cell populations induced from transferred T eff cells, very few of which express CXCR3 (Fig 1D) . In order to directly determine whether CXCR3 is differentially expressed by tT reg 
CXCR3-expressing ICOS + T reg cells adopt a Th1-like phenotype in the pancreatic draining lymph nodes
We investigated whether ICOS + T reg cells expressed markers that would functionally specify them for suppression at sites of type 1 inflammation. Notably, expression of CXCR3 by T reg cells depends on co-expression of Foxp3 and the Th1 lineage specifying transcription factor Tbet [12] . Thus, we predicted T-bet would be co-expressed with CXCR3 by ICOS + T reg cells. We observed a marked co-expression of CXCR3 and T-bet by ex vivo T reg cells in pLN of BDC2.5 NOD mice (Fig 3A) . Moreover, robust T-bet expression was confined to the ICOS + subset of T reg cells in the pLN of BDC2.5 mice and was significantly reduced in ICOS -/-T reg cells suggesting that T-bet expression is partly ICOS-dependent (Fig 3B) . Concordant with CXCR3 expression, there was also a trend of a positive correlation between T-bet expression in ICOS + pT reg / tT reg cells and IFN-γ, which was mostly produced by pancreatic Teff cells, in the adoptive transfer model (Fig 3C and Fig 1C) . Strikingly, following adoptive transfer of T1D, BDC2.5 CXCR3 + ICOS + T reg cells expressed IFN-γ in the pLN, despite their enhanced suppressive potential in the pancreas. The frequency of IFN-γ-expressing T reg cells in the pLN correlated with the degree of pancreatic inflammation (Fig 3D) . Furthermore, we show that ICOS + T reg cells express IFN-γR at higher levels than ICOS -T reg cells at each site examined, consistent with a Th1-like phenotype (Fig 3E) . Thus, unlike ICOS -T reg subset, ICOS + T reg cells adopt a Th1-like phenotype in the draining pancreatic LN that correlates with Th1-polarized inflammation in the pancreas.
Pancreatic antigen presenting cells produce CXCR3 ligands
We then examined the expression of the three CXCR3-activating chemokines, CXCL9, CXCL10 and CXCL11, in the pancreas, which we hypothesized could account for the influx of ICOS + T reg cells from the pLN. Furthermore, as IFN-γ has been shown to induce expression of these chemokines in numerous settings [17, 18] , we predicted that chemokine expression should increase with pancreatic inflammation, along with CXCR3. In 4-week-old BDC2.5 mice, we observed expression of CXCL9, CXCL10, and CXCL11 (Fig 4A and 4B ; data not shown), by APC populations resident to the pancreas, specifically F4/80 + macrophages ( Fig   4A) and CD11c + DCs (Fig 4B) . This level of expression was not observed by lymphoid tissuederived APC subsets (Fig 4A and 4B ; data not shown). To determine whether APC chemokine production could induce specific T reg homing, Transwell assays were performed. To this end, were markedly enriched in the bottom chamber that contained APCs but not those containing media alone (Fig 4E) . Thus, CXCR3 + T reg cells specifically migrated towards the CXCR3 chemokine-producing APC populations in vitro.
In order to examine the effects of different levels of inflammation on chemokine expression NOD.TCRα -/-mice either received CD4 + T cells in order to induce T1D (Fig 4C) or the adoptive transfer experiments were performed as described in Fig 1 (Fig 4D) . Unexpectedly, chemokine expression by APCs did not increase in the presence of BDC2.5 T cell-mediated inflammation in NOD.TCRα -/-recipients, irrespective of T1D outcome (Fig 4C and S1C Fig) .
Furthermore, we found no change in CXCL10 concentrations in pancreatic supernatants or frequency of CXCL9/10 or 11 + APCs in the presence of BDC2.5 T cell-mediated inflammation in NOD.TCRα -/-recipients, irrespective of the transferred BDC2.5 T eff /T reg cell ratio ( Fig 4D and data not shown) . Thus, APC expression of CXCL9, CXCL10 and CXCL11 was confined to the pancreas of BDC2.5 NOD mice but not upregulated in response to inflammation.
Intra-pancreatic Foxp3 + T reg cells express CXCR3 chemokines
Recent evidence indicates that in addition to a range of cytokines, T reg cells can also produce chemokines in certain inflammatory contexts [19] . Thus, we predicted that pancreatic T reg
Fig 3. CXCR3-expressing ICOS + T reg cells adopt a Th1-like phenotype in draining LN. T-bet and CXCR3 co-expression was assessed in ICOS + T reg cells from 4 week old WT BDC2.5 mice (A). T-bet expression (MFI) between ICOS
+ and ICOS -subsets within T reg cells (B cells upregulate CXCR3 chemokines to augment recruitment of T reg cells to the inflammatory lesion. We found that T reg cells in the pancreas, compared to T eff cells, expressed significantly higher levels of CXCL9, CXCL10 and CXCL11 (Fig 4F and data not shown) . This was specific to pancreatic T reg cells, as T reg cells from other sites did not express as high levels of the ligands (Fig 4G) . Intriguingly, the ICOS + subset expressed significantly higher levels of CXCR3 ligands than ICOS -T reg cells (Fig 4H) . Thus, we observed chemokine expression by Foxp3 + T reg cells, which could represent a mechanism of intra-subset regulation of homing into inflamed target organs. 
Intra-islet T reg cells reverse T eff cell-mediated abrogation of chemokine secretion by ß-islet cells
It has recently been established that endocrine β-cells regulate various immune cell subsets during NOD mouse diabetes progression [20] . Therefore, we sought to determine whether endocrine cells in BDC2.5 mice could express CXCR3 chemokines and contribute to the recruitment of T reg cells to pancreatic sites. Using our method recently developed to assess the phenotype and function of pancreatic islet cell populations by flow cytometry [21] we observed substantial expression of CXCL9, CXCL10 and CXCL11 specifically by insulin + β-cells compared to the glucagon + α-cells (Fig 5A) and somatostatin + δ-cells (data not shown). While all three CXCR3 chemokines are expressed in the pancreas, they may not contribute equally to CXCR3 + T reg cell recruitment. The expression of CXCL9 by APCs and β-islet cells was much lower than CXCL10 and CXCL11. Considering CXCL9 is also the lowest affinity ligand and weakest inducer of migration of the three, it may prove less relevant to ICOS + T reg cell trafficking in vivo. Furthermore, as immune-endocrine interactions in hte islets shapediabetogenesis in NOD mice, we evaluated chemokine expression by islet cells during diabetes development. We found that T1D progression induced by T eff cell transfer in NOD.TCRα -/-hosts resulted in impaired CXCL9 and CXCL10 expression by insulin + β-cells (ie live, non-destroyed) (Fig 5B and data not shown). Intriguingly, co-transfer of T reg cells conferred dose-dependent protection from T eff cell-mediated abrogation of chemokine production (Fig 5B) . T reg -derived mediators could directly act on β-cells to induce chemokine expression, or enhance production of chemokines through protection of the islets from T eff mediated cell death. Direct activation of apoptotic pathways by T eff -derived IFN-γ principally drives islet cell death in NOD mice, and indeed we found β cells expressed high levels of IFN-γR in our model compared to α and δ cells (Fig 5C) [26] . Furthermore, co-transfer of T reg cells both reduced intra-pancreatic IFN-γ production by T eff cells and protected β islet cells from cell death as measured by presence of insulin + cells (S1C Fig). Thus, while T eff cell transfer abolishes chemokine expression and drives autoimmunity, T reg cells preserve CXCR3 ligand expression in the islets, perhaps through suppression of T eff cell functions in situ. Overall, our findings indicate that APCs, T reg cells and insulin-producing endocrine cells regulate CXCR3 + T reg cell recruitment from the draining LN to Th1 inflamed pancreatic sites. These findings support the notion that insulin producing β-cells play an active role in modulating T reg cell function in pancreatic sites.
IFN-γ regulates CXCR3 expression and homing of ICOS + T reg cells to islets
We further investigated a role for IFN-γ in the upregulation of CXCR3 on T reg cells. We assessed the expression of IFN-γ receptor (R) by CXCR3 + T reg cells and found that CXCR3 + T reg cells expressed higher levels of IFN-γR than CXCR3 -T reg cells, suggesting that T reg cells that express CXCR3 are more responsive to IFN-γ signaling. To elucidate the association between IFN-γR and CXCR3 expression over the course of T1D development, we examined the co-expression of these markers on donor CD4 + T cells following transfer into NOD.TCRα -/-recipients. Mice were sacrificed on days 3, 6, 9 and 15 and CXCR3, IFN-γR and IFN-γ expression was assessed by flow cytometry on cell suspensions from pLN and pancreas. IFN-γ expression by pancreatic T eff cells increased with T1D progression and peaked at day 9 (data not shown). CXCR3 and IFN-γR expression by ICOS + T reg cells correlated during the time course in all compartments evaluated (Fig 6A and 6B) . Overall, this suggests increased IFN-γR signaling may selectively stimulate ICOS + T reg cells to upregulate CXCR3.
As CXCR3 expression was largely confined to ICOS + T reg cells, we hypothesized that a preferential responsiveness to IFN-γ resulted in upregulation of CXCR3 by this subset. Accordingly, we stimulated T cells isolated from pooled LN and spleen with recombinant IFN-γ, and examined the activity of IFN-γ signaling by assessing STAT1 activation in vitro using flow cytometry. ICOS + T reg cells, not only expressed higher levels of IFN-γR, but demonstrated higher STAT1 phosphorylation upon stimulation, indicating a more sensitive and activated IFN-γR signaling pathway than their ICOS -counterparts, (Fig 6C) . Overall, these results suggested to us that IFN-γ played a role in selective upregulation of CXCR3 by ICOS + T reg cells due to their enhanced sensitivity to this cytokine. We next sought to confirm that IFN-γ regulated CXCR3 expression on ICOS + T reg in vivo.
We predicted that anti-IFN-γ mAb treatment would impair expression of CXCR3 by ICOS + T reg cells upon transfer into NOD.TCRα -/-recipients. To achieve this, we specifically neutralized IFN-γ activity in our transfer system using an anti-IFN-γ monoclonal antibody (mAb, XMG1.2), which potently inhibits IFN-γ in vivo. Our results show that anti-IFN-γ mAb treatment significantly blunted CXCR3 upregulation by ICOS + pT reg cells (Fig 6D) indicating that IFN-γ positively regulates expression of CXCR3 by ICOS + T reg cells during diabetogenesis.
Thus, these results indicate that ICOS + T reg cells detect intra-islet IFN-γ produced by T eff cells during T1D progression, and upregulate CXCR3 to home to the pancreas.
Discussion
Chemokines and chemokine receptors are critical regulators of leukocyte trafficking during the immune response. Selective use of chemokine receptors by T reg cells enables their homing to specific target tissues where they deploy their effector mechanisms to control inflammatory responses, as evidenced in models of infection and cancer. We previously demonstrated that during chronic Leishmania major infection, T reg cells preferentially express CCR5 and home to cutaneous lesions in which they suppress T eff cells and favor pathogen persistence [22] . Similarly, in human chronic liver disease and mouse models of hepatitis, CXCR3 + T reg cells [12] . Likewise, CXCR3 + T reg cells were isolated from human ovarian carcinomas and shown to suppress T eff proliferation and IFN-γ production ex vivo [25] . Studies of T reg cell homing in NOD mice have implicated CXCR3 therein. Indeed, Yamada [26] and colleagues observed accelerated onset of T1D, and decrease pancreatic accumulation of T reg cells in Cxcr3-/-NOD mice. A more recent study in NOD proinsulin 2-/-mice indicated that T reg cells upregulate CXCR3 in the pLN and accumulate in the pancreas [27] . The results described here go further in defining a subpopulation of potently suppressive ICOS+ T reg cells, which expresses CXCR3, the factors and cell types that may regulate T reg cell CXCR3 expression and T reg cell migration to the islets, and the functional and phenotypic characteristics of CXCR3-expressing T reg cells. Specifically, this is the first demonstration, to our knowledge, of ICOS-dependent T reg cell upregulation of trafficking receptors. However, these key findings were also corroborated in the non-TCR transgenic NOD mice, indicating that our proposed model may represent a mechanism of CXCR3 homing of T reg cells to inflamed, non-lymphoid tissues that is conserved across strains (S1D Fig). Finally, this study makes use of a novel, multi-parametric flow cytometry approach for the assessment of endocrine islet cell function and thereby identifies a previously unrecognized role for β-cells in modulating T reg cell responses Diabetes induction by islet-reactive T eff cells severely inhibited chemokine production by β-islet cells; however, their active insulin-secreting status suggests that the loss of chemokine expression by the islet cells is not merely a consequence of their destruction by T eff cells alone. Strikingly, infusion of T reg cells reverses T eff cell-mediated abrogation of chemokine expression by ß-islet cells. This effect could be the result of suppression of intra-islet T eff production of inflammatory cytokines by T reg cells. For instance, T eff -derived IFN-γ can directly promote the apoptosis of islet cells as stat1 -/-islets are resistant to BDC2.5 T eff -mediated killing in vivo [28] . Consistently, our results show that insulin + ß-islet cells express IFN-γR indicating their capacity to respond to IFN-γ in our model. Thus, T reg cell suppression of IFN-γ production in situ may both prevent T eff -mediated destruction of the islets and maintains β-islet production of CXCR3 chemokines that act to recruit T reg cells. Intruigingly, the sole presence of T reg cells in recipient mice augments islet production of CXCL10 suggesting that a direct T reg -islet cell interaction cannot be excluded. An increase in Th1-mediated pancreatic inflammation leads to a dose-dependent upregulation of CXCR3 expression on T reg cells, suggesting that T eff cell-related signals or products, such as IFN-γ, induce mechanisms of pancreatic homing in T reg cells. In other models, CXCR3
+ T reg cells co-express Foxp3 along with the IFN-γ-inducible Th1 lineage specifying transcription factor T-bet, which directly activates transcription of Cxcr3 in addition to promoting responsiveness to IFN-γ through induction of IFN-γR expression [12] . While the expression of CXCR3 has been previously described in T eff cells in murine models and patients with T1D, this is the first demonstration, to our knowledge, of ICOS-regulated CXCR3 expression by Foxp3 + T reg cells [17, 31, 32] . In support of this, we show that CXCR3 and T-bet expression by T reg cells is significantly diminished in ICOS -/-mice. However, ICOS signaling has not been shown to induce T-bet expression by CD4 + T cells. Indeed, ICOS is well known to promote Th2 responses and more recently T-follicular helper cell differentiation, but shown to be unnecessary for Th1 differentiation [33] . However, the factors that govern T-bet expression in T reg cells and Th1 cells may differ. Indeed, IL-12Rβ2 expression, which is indispensible for stable expression of T-bet by Th1 cells, was found to be abrogated during differentiation of CXCR3 + T reg cells [30] . Therefore, in conjunction with IFN-γ signaling, induction of T-bet in T reg cells may require additional stimuli involving ICOS. Previously, we showed that ICOS signals endow T reg cells with an enhanced responsiveness to IL-2. Moreover, IL-2 can induce expression of Tbet in human CD4 + cells in vitro [34] . Therefore, responsiveness to IL-2 could potentially account for differential expression of T-bet between ICOS + and ICOS -T reg cells.
In certain settings such as inflammation or lymphophenia, T reg cells can lose Foxp3 expression, fully reprogram into a T eff cell lineage and contribute to inflammatory processes [29] . Alternatively, recent studies have described transient forms of functional plasticity in T reg cells expressing T eff cell-associated markers critical for their trafficking and the survival at sites of Th1, Th2 or Th17 mediated pathogenesis [30, 13, 14] . Here, we show that CXCR3 + ICOS + T reg cells, the predominant and most immunosuppressive T reg cell subset in the pancreas, express Th1-associated markers including the T-bet transcription factor. Thus ICOS + T reg cells do not completely reprogram into T eff cells but acquire some Th1-like features, which may facilitate their preferential tissue-trafficking and functional fitness. Overall, this indicates that IFN-γ may not solely play a diabetogenic role but could also support tolerogenic mechanisms in the pancreas through regulation of T reg cell homing. Tissue homing of leukocytes profoundly affects immunity, as spatio-temporal coordination of immune cell subsets can dictate the nature of immune response. As homing is increasingly recognized as critical for T reg cell-mediated suppression, it may represent a novel approach to enhancing T reg cell functions. Notably, CXCR3
+ T reg cells were recently shown to indispensably suppress Th1 responses, demonstrating they could be important in type 1 immune-mediated disease [12] . Concordantly, we show in a T1D model that CXCR3 is predominantly expressed by ICOS + T reg cells, presenting an avenue for selective enhancement of this suppressive subset of T reg cells whilst minimizing recruitment of less suppressive ICOS -T reg cells. Though a very low percentage of T eff cells express CXCR3, their use of this receptor cannot be entirely excluded. Thus, further elucidation of the factors that specifically modulate ICOS + T reg cell trafficking is required. If these are amenable to therapeutic modulation, their enhancement could potently dampen inflammation and control autoimmunity.
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